Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/684,759external-prioritypatent/US4935495A/en
Priority claimed from US06/776,321external-prioritypatent/US4906562A/en
Application filed by OncogenfiledCriticalOncogen
Publication of FI923418ApublicationCriticalpatent/FI923418A/fi
Publication of FI923418A0publicationCriticalpatent/FI923418A0/fi
Publication of FI94291BpublicationCriticalpatent/FI94291B/fi
Application grantedgrantedCritical
Publication of FI94291CpublicationCriticalpatent/FI94291C/fi
Verwendung eines spezifischen karzinomassoziierenden antigens (hapten), fucosylsialosylgangliotetrose (fuc-gm1) in diagnostischen und therapeutischen verfahren betreffend den menschlichen lungenkrebs (carcinomas von kleinen zellen).
Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same